GLP-1 Food Noise: Appetite Tracking in Pokii

Where the term "food noise" came from

"Food noise" wasn't coined by a clinician or introduced through a peer-reviewed study — it started as a patient description that spread through personal accounts and media coverage before researchers began paying close attention to it. An expert panel convened at the American Society of Nutrition's June 2024 meeting, later summarized in the journal Nutrition & Diabetes, offered a working definition: persistent thoughts about food that a person experiences as unwanted or distressing, and that may cause social, mental, or physical problems. That definition is a useful starting point, but it remains an early, working one rather than an established diagnostic standard.

Search interest in the phrase tells its own story. According to data cited in that Nutrition & Diabetes review, "food noise" was first searched online back in 2006, but interest stayed minimal for over a decade, then climbed sharply starting in fall 2022, around the same time GLP-1 medications saw a surge in use for weight loss, peaking in spring 2024. Researchers are actively working on ways to formally measure food noise, including a proposed food noise inventory, but there is still no single, validated clinical tool for scoring or diagnosing it. Without an agreed-upon measurement, most of what's reported about food noise remains descriptive rather than clinically quantified.

Why GLP-1 medications are widely reported to quiet it

The honest answer is that researchers don't yet have a fully settled explanation. What's widely reported is that many people taking GLP-1 receptor agonists, and dual GLP-1/GIP medications, notice a reduction in food noise, sometimes fairly soon after starting. Scientists and science journalists who study this describe it as plausibly involving more than the well-established gut effects of these drugs, such as slowed digestion and gastric emptying — the current, still-developing thinking is that the brain's own appetite and reward circuitry may also be involved.

GLP-1 receptors exist not only in the gut and pancreas but also in the brain, including the hypothalamus, which helps regulate hunger and fullness, and reward-related regions such as the nucleus accumbens, tied to the pleasure and motivation people feel around food. The body's own GLP-1 is short-lived and is not thought to reach the brain in large amounts on its own, but researchers believe the brain also produces GLP-1 through neurons in the brainstem, and that longer-acting synthetic GLP-1 medications may act on some of these same central pathways for sustained stretches of time. Early evidence, drawn from animal studies and from human studies showing reduced brain reward-region response to food cues during GLP-1 therapy, supports the idea of a central, brain-based effect alongside the peripheral, gut-based one. Researchers describe this as an emerging picture rather than a fully mapped mechanism, and generally use cautious language like "thought to" and "believed to" instead of presenting it as settled fact.

That caution is worth taking seriously. A November 2025 case study from the University of Pennsylvania's Perelman School of Medicine, published in Nature Medicine, used a brain-computer interface to observe brain activity linked to food noise in a patient taking tirzepatide. The medication's effect on that reward-related brain signaling appeared temporary and incomplete, and the researchers cautioned that it is far too soon to consider GLP-1/GIP medications a broadly effective treatment for food noise or related conditions beyond their approved uses for diabetes and obesity. The brain-mechanism story is real and actively being studied, but it isn't yet a settled, complete explanation.

What's still uncertain about food noise and GLP-1s

Several things about food noise remain genuinely unresolved. First, it is not universal — reporting and clinical commentary consistently note that not everyone on a GLP-1 medication experiences a reduction in food noise, and among those who do, how much it changes varies widely and isn't well understood. Some people continue to notice food noise even at higher doses. Second, it still isn't a formal diagnosis. It has no agreed-upon clinical definition or diagnostic criteria, and while people sometimes describe it in language that echoes eating disorders, it is a distinct, informal concept rather than a clinical condition on its own.

Third, the effect can fluctuate rather than stay constant. Because GLP-1 medications have a defined half-life, blood levels taper as a dose wears off, and anecdotally, the food-noise-quieting effect can taper along with it, for example in the days leading up to a weekly injection. Fourth, the effect has not been shown to be uniform across the drug class. Reductions are reported anecdotally and in early research across multiple GLP-1 and GLP-1/GIP medications, not just one brand, and some secondary sources suggest dual-agonist drugs like tirzepatide may produce steadier suppression across a dosing week than GLP-1-only medications. But rigorous, head-to-head research isolating food noise specifically, rather than weight loss or general hunger scores, is still limited, so drug- and dose-specific comparisons should be treated as preliminary.

Tracking your own appetite and mood pattern in Pokii

Pokii is a tracking and education tool — it does not provide medical advice, diagnosis, or treatment, and it does not measure or label "food noise" as a clinical concept. What it does offer is a simple, consistent way to log the day-to-day experiences that many people associate with food noise shifting over time. The free daily check-in includes a dedicated appetite slider and a dedicated mood slider, separate from generic side-effect tags, along with optional side-effect logging and free-text notes. Each check-in shows a relative-to-last hint, making it easy to see at a glance whether appetite is trending up, down, or holding steady compared to the previous entry.

Every check-in is tied to the day it was logged and shows up in Today's log, a unified dashboard timeline alongside that day's shot, weight entry, or food scan, as well as on the Calendar tab in month or list view, making it easier to view appetite and mood alongside dosing timing rather than reconstructing it from memory later. For meal context, You can photograph meals for AI-estimated nutrition, editing the estimate before saving; that data writes to Apple Health, so the nutrition dashboard's calories, protein, carbs, fat, fiber, sugar, and sodium totals update alongside the day's appetite and mood entries. For anyone who wants to review the pattern over a longer stretch, or share it with a prescriber, PDF progress reports can include appetite and mood history as optional sections, alongside weight, shots, and side effects.